Publications: Gibson, Andrew

Journal Article

Hama, N., Abe, R., Gibson, A. and Phillips, E.J. (2022) Drug-Induced Hypersensitivity Syndrome (DIHS)/ Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis. The Journal of Allergy and Clinical Immunology: In Practice, 10 (5). pp. 1155-1167.

Goldman, J.L., Miller, J.O., Miller, N., Eveleigh, R., Gibson, A., Phillips, E.J. and Pastinen, T. (2022) HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure. The Pharmacogenomics Journal, 22 . pp. 124-129.

Deshpande, P., Li, Y., Thorne, M., Palubinsky, A.M., Phillips, E.J. and Gibson, A. (2022) Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity. The Journal of Allergy and Clinical Immunology: In Practice .

Hertzman, R.J., Deshpande, P., White, K.D., Gangula, R., Chopra, A., Ram, R., Zic, J.A., Zwerner, J.P., Gibson, A. and Phillips, E.J. (2022) Single-cell immunopathology of systemic contact allergy associated with corticosteroids. Journal of Dermatological Science, 105 (2). pp. 137-140.

Gibson, A., Li, Y., Thorne, M., Ram, R., Palubinsky, A., Choshi, P., Porter, M., Trubiano, J., Deshpande, P., Chopra, A., Leary, S., Gangula, R., White, K., Pilkington, M., Konvinse, K., Wang, C-W, Pan, R-Y, Hung, S-I, Chung, W-H, Peter, J., Mallal, S. and Phillips, E. (2022) Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) tissue damage. Journal of Allergy and Clinical Immunology, 149 (2). Art. AB181.

Li, Y., Deshpande, P., Chopra, A., Choo, L., Gibson, A. and Phillips, E.J. (2022) A low‐cost, sensitive and specific PCR ‐based tool for rapid clinical detection of HLA‐B*35 alleles associated with delayed drug hypersensitivity reactions. HLA .

Awad, A., Mouhtouris, E., Nguyen-Robertson, C.V., Holmes, N., Chua, K.Y.L., Copaescu, A., James, F., Goh, M.S., Aung, A.K., Godfrey, D.I., Phillips, E.J., Gibson, A., Almeida, C.F. and Trubiano, J.A. (2021) Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis. Journal of Allergy and Clinical Immunology: Global . In Press.

Hammond, S., Olsson-Brown, A., Grice, S., Gibson, A., Gardner, J., Castrejón-Flores, J.L., Jolly, C., Fisher, B.A., Steven, N., Betts, C., Pirmohamed, M., Meng, X. and Naisbitt, D.J. (2021) Checkpoint inhibition reduces the threshold for Drug-Specific T-Cell priming and increases the incidence of sulfasalazine hypersensitivity. Toxicological Sciences, 186 (1). pp. 58-69.

Nakkam, N., Trubiano, J., Gibson, A. and Phillips, E.J. (2021) Considerations for cross-reactivity between vancomycin and other glycopeptides. The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). Art. 3233.

Li, Y., Deshpande, P., Hertzman, R.J., Palubinsky, A.M., Gibson, A. and Phillips, E.J. (2021) Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions. Frontiers in Genetics, 12 . Art. 641905.

Deshpande, P., Hertzman, R.J., Palubinsky, A.M., Giles, J.B., Karnes, J.H., Gibson, A. and Phillips, E.J. (2021) Immunopharmacogenomics: Mechanisms of HLA‐Associated Drug Reactions. Clinical Pharmacology & Therapeutics, 110 (3). pp. 607-615.

Hertzman, R.J., Deshpande, P., Gibson, A. and Phillips, E.J. (2021) Role of pharmacogenomics in T-cell hypersensitivity drug reactions. Current Opinion in Allergy & Clinical Immunology, 21 (4). pp. 327-334.

Hertzman, R., Deshpande, P., White, K., Gangula, R., Chopra, A., Ram, R., Leary, S., Zic, J., Zwerner, J., Gibson, A. and Phillips, E. (2021) Single-cell immunopathology of systemic contact allergy associated with corticosteroids. Journal of Allergy and Clinical Immunology, 147 (2). AB31.

Hertzman, R.J., Deshpande, P., Leary, S., Li, Y., Ram, R., Chopra, A., Cooper, D., Watson, M.ORCID: 0000-0002-6438-9225, Palubinsky, A.M., Mallal, S., Gibson, A. and Phillips, E.J. (2021) Visual genomics analysis studio as a tool to analyze multiomic data. Frontiers in Genetics, 12 . Art. 642012.

Copaescu, A., Gibson, A., Li, Y., Trubiano, J.A. and Phillips, E.J. (2021) An updated review of the diagnostic methods in delayed drug hypersensitivity. Frontiers in Pharmacology, 11 . Art. 573573.

Nakkam, N., Gibson, A., Mouhtouris, E., Konvinse, K., Holmes, N., Chua, K.Y., Deshpande, P., Li, D., Ostrov, D.A., Trubiano, J. and Phillips, E.J. (2020) Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype. Journal of Allergy and Clinical Immunology, 147 (1). P403-P405.

Naisbitt, D.J., Park, B.K., Sakatis, M.Z., Hillegas, A., Gibson, A., Faulkner, L., Lister, A., Watkinson, J. and Ogese, M.O. (2020) Development of an Improved T-cell assay to assess the intrinsic immunogenicity of haptenic compounds. Toxicological Sciences, 175 (2). pp. 266-278.

Mangan, B.L., McAlister, R.K., Balko, J.M., Johnson, D.B., Moslehi, J.J., Gibson, A. and Phillips, E.J. (2020) Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. British Journal of Clinical Pharmacology . Early View.

Copaescu, A., Smibert, O., Gibson, A., Phillips, E.J. and Trubiano, J.A. (2020) The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. Journal of Allergy and Clinical Immunology, 146 (3). 518-534.e1.